Authors' Reply to: Tocilizumab, Adipokines and Severe Complications of COVID-19
Clin Drug Investig
.
2020 Sep;40(9):893-895.
doi: 10.1007/s40261-020-00948-w.
Authors
Bin Liu
1
,
Zhigang Qi
2
Affiliations
1
Nephrology Department, Wuxi People's Hospital Attached to Nanjing Medical University, Wuxi, 214023, Jiangsu, China.
2
Department of Pharmacy, Wuxi People's Hospital Attached to Nanjing Medical University, Wuxi, 214023, Jiangsu, China. qizhigang058518@163.com.
PMID:
32661911
PMCID:
PMC7357256
DOI:
10.1007/s40261-020-00948-w
No abstract available
Publication types
Letter
Comment
Grants and funding
NZ2019004/Wuxi Municipal Bureau on Science and Technology/International